Clinical trial
ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated…
NCT00283361 · Zealand Pharma, Industry · Terminated
Key facts
| NCT number | NCT00283361 |
|---|---|
| Title | ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure |
| Official title | A Phase II,Randomized, Double-Blind, Flexible Dose Study of ZP120 I.V. Infusion as Add-On Therapy in Patients With Acute or Sub-Acute Decompensated Chronic Heart Failure NYHA Class III-IV Treated With Furosemide |
| Lead sponsor | Zealand Pharma, Industry |
| Collaborators | Syneos Health |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Behavioral, Drug, Procedure |
| Interventions | ZP120, I.v. catherization, 6-minutes walk performance, Dyspnea severity assessment, Blood sampling for laboratory tests, ECG, Physical examination |
| Enrollment | 130 |
| Start date | Jan 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jan 27, 2006 |
| Last update posted | Feb 28, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: